Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ABSORB BTK Study: A Prospective, Multi-center, Controlled Clinical Evaluation of the Use of a Bioresorbable Drug Eluting Stent (Absorb, Abbott Vascular) in the Arterial Vasculature Below the Knee

NCT02793349 is registered in ClinicalTrials.gov with The University of New South Wales as lead sponsor.

NCT NCT02793349
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02793349 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ABSORB BTK Study: A Prospective, Multi-center, Controlled Clinical Evaluation of the Use of a Bioresorbable Drug Eluting Stent (Absorb, Abbott Vascular) in the Arterial Vasculature Below the Knee
Lead sponsor
The University of New South Wales
Phase
Not applicable
Overall status
Terminated
Start date
June 30, 2015
Completion date
June 30, 2017
Enrollment
4 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

arterial occlusive diseases, ischemia, peripheral arterial disease (pta